Login

The 2022 Dining Service Contest by Global-Dining, Inc. highlights essential insights for restaurant owners, focusing on managing closure rates. 00:10:00

Share On Facebook Share On Twitter

Kozo Hasegawa. CEO at Global-Dining, Inc

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Sun Products' Strategic Growth and Market Transformation
00:10:00
Spotlight on Jennifer Johnson: Impact Investing Leader
00:00:00
Biotec Pharmacon presentation - Christian Jorgensen, CEO, Biotec Pharmacon A
00:10:00
3D Metalforge Partners with Renishaw for Future-Proof Additive Manufacturing Solutions | Matt Waterhouse , CEO ,3D Metal Forge Ltd.
00:10:00
James P. Scriven, CEO of IDB Invest, explores Latin American finance and investment strategies with the International Finance Corporation.
00:10:00
Fortuna Silver Mines Inc. prioritizes sustainability in its global precious metals mining operations, fostering efficient production, environmental stewardship, and social responsibility to create long-term shared value for stakeholders.|Jorge A. Ganoza c
00:10:00
curiosity to understand the changing world around us|Steve Kraus,Partner,Bessemer Venture Partners
00:10:00
Steve Parsons on Goldsource Mines and Eagle Mountain Project Overview
00:10:00
Soldiers in Revolt: A Personal Journey Through Vietnam War Resistance|David Cortright,Professor,University of Notre Dame
00:10:00
Insights from Brad Boat of Capital Group's American Funds|Bradley J. Vogt,manager,capital Group
00:00:00
Charles J. Bruce, M.B., Ch.B. Cardiologist, Mayo Clinic
00:10:00
Ian Roper on Commodities and the Energy Transition: Focus on Copper's Role Beyond EVs

© 2017 - Neuhu+